D-lactic acidosis

Background

  • D-lactic acidosis (D-lactate encephalopathy) is a rare cause of anion gap metabolic acidosis with neurologic symptoms that occurs primarily in patients with short bowel syndrome (SBS) and an intact colon[1]
  • Pathophysiology:
    • Humans produce almost exclusively L-lactate; D-lactate is the mirror-image (enantiomer) produced by bacterial metabolism
    • In SBS, unabsorbed carbohydrates reach the colon where they are fermented by colonic bacteria (Lactobacillus, Streptococcus bovis, and other acid-resistant organisms) into organic acids including D-lactic acid
    • The resulting acidic colonic environment further favors overgrowth of D-lactate-producing organisms → vicious cycle of escalating D-lactate production[1]
    • Humans metabolize D-lactate much more slowly than L-lactate (via D-2-hydroxy acid dehydrogenase), so D-lactate accumulates in the blood
    • D-lactate crosses the blood-brain barrier and causes neurologic dysfunction[2]
  • Conditions associated with D-lactic acidosis:
    • Short bowel syndrome (most common) — from surgical resection (Crohn's disease, mesenteric ischemia, volvulus, NEC, trauma), congenital abnormalities, or historical jejunoileal bypass for obesity[1]
    • Small intestinal bacterial overgrowth (SIBO)
    • Rarely: diabetes mellitus with intestinal dysmotility, chronic antibiotic use altering gut flora
  • Episodes are typically precipitated by high carbohydrate meals (provides substrate for bacterial fermentation)[3]
  • The key diagnostic challenge: Standard laboratory L-lactate assays do NOT detect D-lactate — a normal reported "lactic acid" does not exclude D-lactic acidosis[4]

Clinical Features

  • Presentation is characterized by recurrent episodic encephalopathy and metabolic acidosis — typically following carbohydrate-rich meals
  • Neurologic symptoms predominate (present in virtually all reported cases):[1]
    • Altered mental status (confusion, disorientation, lethargy → stupor → coma)
    • Slurred speech
    • Ataxia and gait disturbance (often described as appearing "intoxicated")
    • Impaired motor coordination
    • Nystagmus
    • Irritability, hostile/aggressive/bizarre behavior
    • Weakness
    • Headache
  • GI symptoms:
    • Nausea, vomiting
    • Abdominal pain/distension (often chronic from underlying SBS)
    • Diarrhea
  • Classic pattern: Symptoms develop hours after a high-carbohydrate meal in a patient with known SBS, and resolve with fasting and correction of acidosis
  • Neurologic symptoms may occur without significant acidosis in some cases, suggesting direct neurotoxicity of D-lactate beyond its contribution to acidosis[1]
  • Episodes are recurrent — patients often present repeatedly before the diagnosis is made

Differential Diagnosis

Evaluation

Workup

  • BMP/CMP: Anion gap metabolic acidosis (elevated anion gap); electrolytes, bicarbonate, BUN/creatinine, glucose
  • ABG/VBG: Confirm metabolic acidosis; calculate anion gap
  • Standard L-lactate level: May be normal or mildly elevated — a normal L-lactate in the setting of unexplained AGMA in a SBS patient should raise suspicion for D-lactic acidosis[1]
  • D-lactate level: This is the confirmatory test
    • Normal: < 0.25 mmol/L
    • Diagnostic: > 3 mmol/L[4]
    • This is a send-out test — NOT available on routine chemistry panels or point-of-care testing; results may take days
    • Diagnosis must often be made clinically before results return
  • Serum ketones: To exclude DKA and alcoholic ketoacidosis
  • Serum ethanol, acetaminophen, salicylate levels: Exclude co-ingestants and toxic alcohols
  • Serum osmolality and osmolar gap: Exclude toxic alcohol ingestion
  • CBC: Leukocytosis may suggest alternative diagnosis (sepsis, ischemia)
  • LFTs, ammonia: Exclude hepatic encephalopathy
  • Thiamine level: Consider in malnourished SBS patients (Wernicke can coexist)
  • Blood cultures: If febrile or concern for line sepsis
  • CT abdomen: Consider to exclude bowel obstruction, bowel dilatation, or ischemia as alternative/contributing diagnoses

Diagnosis

  • Diagnosis is primarily clinical — suspect D-lactic acidosis when:
    • Anion gap metabolic acidosis PLUS encephalopathy/neurologic symptoms PLUS history of SBS or intestinal malabsorption PLUS normal or mildly elevated L-lactate
  • The "lactate gap" — unexplained anion gap metabolic acidosis with normal L-lactate — is the hallmark laboratory clue[2]
  • Confirmed by serum D-lactate > 3 mmol/L, but treatment should not be delayed pending this result
  • Other organic acids (D-2-hydroxyisovaleric acid, D-2-hydroxyisocaproic acid) may contribute to the anion gap but are not routinely measured

Management

Acute Treatment

  • NPO / fasting: Eliminates carbohydrate substrate for bacterial D-lactate production — this is the single most important acute intervention[1]
    • IV fluids for hydration during fasting period
    • Typically 24 hours of fasting followed by slow reintroduction of a low-carbohydrate diet
  • IV sodium bicarbonate: For significant metabolic acidosis (pH < 7.2 or hemodynamically significant); correct acidosis gradually
  • IV thiamine: 100 mg IV — administer empirically in all malnourished SBS patients (thiamine deficiency may coexist and mimics/worsens encephalopathy; thiamine is also a cofactor in D-lactate metabolism)[2]
  • Enteral antibiotics: Target D-lactate-producing colonic flora[1]
    • Metronidazole (oral)
    • Oral vancomycin
    • Oral neomycin or kanamycin
    • Choice is often empiric; rotation may be needed for recurrent episodes
  • Correct electrolyte abnormalities
  • Avoid Lactated Ringer's solution — while LR contains only L-lactate and should not worsen D-lactic acidosis, normal saline is preferred to avoid any confusion

Prevention of Recurrence

  • Low-carbohydrate diet: Reduce simple sugars and refined carbohydrates to limit substrate for bacterial fermentation — cornerstone of long-term management[3]
  • Probiotics: Non-D-lactate-producing strains (e.g. Lactobacillus rhamnosus GG, Saccharomyces boulardii) to recolonize with favorable flora — evidence is limited but promising[4]
  • Intermittent or cycling enteral antibiotics: Reduce bacterial overgrowth
  • Optimize SBS management: GI/nutrition consultation for intestinal rehabilitation, dietary counseling, parenteral nutrition adjustment
  • Surgical options (refractory cases): Intestinal lengthening procedures, small bowel transplant, or colectomy (eliminates the site of D-lactate production — last resort)[1]

Disposition

  • Admit:
    • All patients with suspected or confirmed D-lactic acidosis
    • Significant metabolic acidosis requiring IV bicarbonate
    • Altered mental status (monitor for airway compromise)
    • Inability to tolerate oral intake
    • Need for IV hydration and serial lab monitoring
  • ICU admission:
    • Severe encephalopathy (GCS significantly depressed, inability to protect airway)
    • Hemodynamic instability
    • Severe acidosis (pH < 7.1)
  • Consultations:
    • GI / nutrition: For long-term SBS management, dietary counseling, and prevention of recurrence
    • Medical toxicology: If diagnostic uncertainty regarding anion gap etiology
    • Surgery: If bowel obstruction, ischemia, or surgical SBS management is being considered
  • Discharge:
    • Once neurologic symptoms have fully resolved, acidosis has corrected, and patient tolerates oral low-carbohydrate diet
    • Arrange close GI follow-up
    • Provide dietary counseling: avoid high-sugar/high-carbohydrate meals
    • Educate patient/family on recognition of recurrent episodes and need for early ED presentation
  • Prognosis: With appropriate treatment, acute episodes typically resolve within 24–48 hours of fasting and supportive care; long-term prognosis depends on the underlying SBS and dietary adherence[1]

See Also

External Links

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 Kowlgi NG, Chhabra L. D-lactic acidosis: an underrecognized complication of short bowel syndrome. Gastroenterol Res Pract. 2015;2015:476215. PMID 25977687.
  2. ↑ 2.0 2.1 2.2 Petersen C. D-lactic acidosis. Nutr Clin Pract. 2005;20(6):634-645. PMID 16306300.
  3. ↑ 3.0 3.1 Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis: a review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore). 1998;77(2):73-82. PMID 9556700.
  4. ↑ 4.0 4.1 4.2 Bustos D, Pernas JC, Perez-Ayuso E, et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg. 2004;39(2):e5. PMID 15065046.
Retrieved from "https://www.wikem.org/w/index.php?title=D-lactic_acidosis&oldid=389200"